Modified FOLFOX6 with or without radiation in neoadjuvant treatment of locally advanced rectal cancer: Final results of the Chinese FOWARC multicenter randomized trial.
Yanhong Deng(Sun Yat-sen University), Jianping Wang(Sun Yat-sen University), Zong-hai Huang(University of Electronic Science and Technology of China), Long Cui(Jiangsu Normal University), Chen Daoda(Huazhong University of Science and Technology), Yiding Luo(First Affiliated Hospital of Xiamen University), Hao Zhang(Dongguan People’s Hospital), Lei Wang(Sun Yat-sen University), Jie Cao(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongbo Wei(Sun Yat-sen University), Pan Chi(Fujian Medical University), Hongfeng Zhou, Jian Zheng(Sun Yat-sen University), Ren Zhao(Shanghai Jiao Tong University), Weiqing Chen(Chongqing University), Ping Lan(Sun Yat-sen University), Guanfu Cai(Guangdong Provincial People's Hospital), Xiang Peng, Zhongcheng Huang(Zhujiang Hospital), Yisheng Wei(Second Affiliated Hospital of Guangzhou Medical University)
Cited by 18
Related Papers
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
|Clinical Cancer Research|2018|456
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
|JAMA|2018|410
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
|Journal of Clinical Oncology|2019|410
Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial
|Journal of Clinical Oncology|2016|409
BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing
|Nature|2017|402